Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Clinical trial NCT05604287 · TERMINATED

Trial details

NCT number: NCT05604287
Sponsor: IlDong Pharmaceutical Co Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-10-10
Primary completion: 2024-04-12
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.